Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313503211> ?p ?o ?g. }
- W4313503211 endingPage "25" @default.
- W4313503211 startingPage "25" @default.
- W4313503211 abstract "ERK3 and ERK4 define a distinct and understudied subfamily of mitogen-activated protein kinases (MAPKs). Little is known about the physiological roles of these atypical MAPKs and their association with human diseases. Interestingly, accumulating evidence points towards a role for ERK3 and ERK4 signaling in the initiation and progression of various types of cancer. Notably, a recent study reported that ERK4 is expressed in a subset of triple-negative breast cancer (TNBC) cell lines and that this expression is critical for AKT activation and for sustaining TNBC cell proliferation in vitro and tumor growth in mice. The authors also showed that depletion of ERK4 sensitizes TNBC cells to phosphatidylinositol-3-kinase (PI3K) inhibitors. They concluded that ERK4 is a promising therapeutic target for TNBC and has potential for combination therapy with PI3K inhibitors. Here, we raise concerns about the cellular models and experimental approaches used in this study, which compromise the conclusions on the oncogenic role of ERK4 in TNBC." @default.
- W4313503211 created "2023-01-06" @default.
- W4313503211 creator A5005653194 @default.
- W4313503211 creator A5012137578 @default.
- W4313503211 creator A5023717901 @default.
- W4313503211 creator A5037929534 @default.
- W4313503211 creator A5046441034 @default.
- W4313503211 creator A5062536288 @default.
- W4313503211 creator A5083345616 @default.
- W4313503211 creator A5085198110 @default.
- W4313503211 date "2022-12-21" @default.
- W4313503211 modified "2023-09-30" @default.
- W4313503211 title "On the Therapeutic Potential of ERK4 in Triple-Negative Breast Cancer" @default.
- W4313503211 cites W1507957953 @default.
- W4313503211 cites W1836306146 @default.
- W4313503211 cites W1973460380 @default.
- W4313503211 cites W1977472414 @default.
- W4313503211 cites W1989876648 @default.
- W4313503211 cites W1990065094 @default.
- W4313503211 cites W2012034410 @default.
- W4313503211 cites W2043398720 @default.
- W4313503211 cites W2046217468 @default.
- W4313503211 cites W2057923468 @default.
- W4313503211 cites W2085362455 @default.
- W4313503211 cites W2107939178 @default.
- W4313503211 cites W2110283088 @default.
- W4313503211 cites W2113030486 @default.
- W4313503211 cites W2148014088 @default.
- W4313503211 cites W2161028192 @default.
- W4313503211 cites W2161105936 @default.
- W4313503211 cites W2168259122 @default.
- W4313503211 cites W2728981453 @default.
- W4313503211 cites W2741508285 @default.
- W4313503211 cites W2912656088 @default.
- W4313503211 cites W2918171554 @default.
- W4313503211 cites W2919753789 @default.
- W4313503211 cites W3045269792 @default.
- W4313503211 cites W3100827678 @default.
- W4313503211 cites W3133049234 @default.
- W4313503211 cites W3165290637 @default.
- W4313503211 cites W4206087364 @default.
- W4313503211 cites W4221061854 @default.
- W4313503211 cites W4255987158 @default.
- W4313503211 doi "https://doi.org/10.3390/cancers15010025" @default.
- W4313503211 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36612022" @default.
- W4313503211 hasPublicationYear "2022" @default.
- W4313503211 type Work @default.
- W4313503211 citedByCount "1" @default.
- W4313503211 countsByYear W43135032112023 @default.
- W4313503211 crossrefType "journal-article" @default.
- W4313503211 hasAuthorship W4313503211A5005653194 @default.
- W4313503211 hasAuthorship W4313503211A5012137578 @default.
- W4313503211 hasAuthorship W4313503211A5023717901 @default.
- W4313503211 hasAuthorship W4313503211A5037929534 @default.
- W4313503211 hasAuthorship W4313503211A5046441034 @default.
- W4313503211 hasAuthorship W4313503211A5062536288 @default.
- W4313503211 hasAuthorship W4313503211A5083345616 @default.
- W4313503211 hasAuthorship W4313503211A5085198110 @default.
- W4313503211 hasBestOaLocation W43135032111 @default.
- W4313503211 hasConcept C121608353 @default.
- W4313503211 hasConcept C126322002 @default.
- W4313503211 hasConcept C132149769 @default.
- W4313503211 hasConcept C184235292 @default.
- W4313503211 hasConcept C2780110267 @default.
- W4313503211 hasConcept C502942594 @default.
- W4313503211 hasConcept C530470458 @default.
- W4313503211 hasConcept C55493867 @default.
- W4313503211 hasConcept C60644358 @default.
- W4313503211 hasConcept C62112901 @default.
- W4313503211 hasConcept C62478195 @default.
- W4313503211 hasConcept C71924100 @default.
- W4313503211 hasConcept C75217442 @default.
- W4313503211 hasConcept C86554907 @default.
- W4313503211 hasConcept C86803240 @default.
- W4313503211 hasConcept C95444343 @default.
- W4313503211 hasConceptScore W4313503211C121608353 @default.
- W4313503211 hasConceptScore W4313503211C126322002 @default.
- W4313503211 hasConceptScore W4313503211C132149769 @default.
- W4313503211 hasConceptScore W4313503211C184235292 @default.
- W4313503211 hasConceptScore W4313503211C2780110267 @default.
- W4313503211 hasConceptScore W4313503211C502942594 @default.
- W4313503211 hasConceptScore W4313503211C530470458 @default.
- W4313503211 hasConceptScore W4313503211C55493867 @default.
- W4313503211 hasConceptScore W4313503211C60644358 @default.
- W4313503211 hasConceptScore W4313503211C62112901 @default.
- W4313503211 hasConceptScore W4313503211C62478195 @default.
- W4313503211 hasConceptScore W4313503211C71924100 @default.
- W4313503211 hasConceptScore W4313503211C75217442 @default.
- W4313503211 hasConceptScore W4313503211C86554907 @default.
- W4313503211 hasConceptScore W4313503211C86803240 @default.
- W4313503211 hasConceptScore W4313503211C95444343 @default.
- W4313503211 hasFunder F4320310758 @default.
- W4313503211 hasFunder F4320311169 @default.
- W4313503211 hasFunder F4320324181 @default.
- W4313503211 hasIssue "1" @default.
- W4313503211 hasLocation W43135032111 @default.
- W4313503211 hasLocation W43135032112 @default.
- W4313503211 hasLocation W43135032113 @default.